Skip to content

  • Twitter
  • Telegram
  • Instagram
  • YouTube
  • GAB
  • Français
  • Español
  • Home
  • Noteworthy News
  • Short Posts
  • In Depth
    • Guest Articles
  • TOP 15
  • Webinars
  • Interviews
  • Podcast

Oxford Professor Horby Claims Professor Landray was Misquoted – France-Soir Newspaper Denies It

Posted on June 11, 2020June 17, 2020 by covexit

While the hydroxychloroquine arm of the RECOVERY Randomized Clinical Trial was terminated last Friday, the research continues to make waves in the French media, seemingly

Noteworthy News

Early Treatment for COVID-19 as Implemented by General Practitioners in France

Posted on June 11, 2020June 11, 2020 by covexit

General practitioners and specialized doctors operating outside hospital settings played a key role in the fight against COVID-19 in France. There are over 100,000 of

In Depth Articles, Noteworthy News

A Highly Viral Video by the Oxford RECOVERY Trial?

Posted on June 10, 2020June 17, 2020 by covexit

There is a video on YouTube showing how to seek consent from volunteer patients to participate in the RECOVERY trial.  The video, which serves as

Noteworthy News

Professor Raoult Compares the Oxford RECOVERY Trial Academics to the Marx Brothers

Posted on June 9, 2020June 17, 2020 by covexit

In a video interview today, Professor Didier Raoult, from IHU-Marseille, blasts the Oxford academics having carried out the RECOVERY randomized controlled trials having tested hydroxychloroquine

Noteworthy News

RECOVERY COVID-19 Oxford Research Blasted for Toxic Dosage: Towards #OxfordGate?

Posted on June 8, 2020June 17, 2020 by covexit

This June 6th, the France-Soir newspaper published an article titled “Recovery: Brexit & “Overdose”” which points at “very high” fatality rates in the Oxford /

Noteworthy News

COVID-19 and the Young – Clip #6 of Prof. J. Varon Interview

Posted on June 5, 2020June 6, 2020 by covexit

This is the sixth clip our interview with Professor J. Varon, MD, where he talks about COVID-19 and the young, who are not invincible, and

Noteworthy News, Video Interviews

UK RECOVERY Trial: Inadequate Hydroxychloroquine Treatment Predictably Fails

Posted on June 5, 2020June 15, 2020 by covexit

While the first results of the UK RECOVERY trials were expected for July, they were unexpectedly released today June 5. With the epidemic still going

In Depth Articles, Noteworthy News

The Controversy on the Effectiveness of Hydroxychloroquine / Azithromycin to Treat COVID-19

Posted on June 5, 2020November 5, 2020 by covexit

by Jacques Pollini, PhD, Research Associate, Department of Anthropology, McGill University Note: the French version of the article is available at this link. A surrealistic

Guest Articles, Noteworthy News

COVID-19 Prevention: Is Post Exposure Prophylaxis an Oxymoron?

Posted on June 4, 2020June 7, 2020 by covexit

Here is a dive into the study on “post-exposure prophylaxis” for COVID-19, recently published in the New England Journal of Medicine. The present article challenges

In Depth Articles, Noteworthy News

Thousands Can Still be Saved from COVID-19

Posted on June 3, 2020June 3, 2020 by covexit

Jean-Pierre Kiekens is an independent policy analyst. He is a former lecturer at the University of Brussels and a graduate of the universities of Oxford

In Depth Articles, Noteworthy News

Association of American Physicians & Surgeons Sues the FDA over Hydroxychloroquine Restrictions

Posted on June 2, 2020June 2, 2020 by covexit

The Association of American Physicians & Surgeons has announced it filed a lawsuit against the Food and Drug Administration “to end its arbitrary interference with

Noteworthy News

Azithromycin Alone Also Accelerates Recovery from COVID-19 — Study

Posted on June 1, 2020June 1, 2020 by covexit

A study titled “Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19” was published as a pre-print. The study, authored by French medical doctors

Noteworthy News

Posts navigation

«Previous Posts 1 … 19 20 21 22 23 … 32 Next Posts»

SHORT POSTS

  • Covexit is on Substack
  • Update: Outbreaks & Deaths Continue to Rise in Québec Nursing Homes
  • Djokovidelirum Hits Australia
  • Should Uttar Pradesh be an Example to the World?
  • Potentially Super-Spreading Events Allowed in Australia?

Newsletter

Trending


  • Webinar with Professor Paul Marik: the Prevention & Outpatient Treatment of C19intro slide paul marik.001 by Covexit December 17, 2020 Today, there is a crisis in hospitals in the US and many other countries, where C19 is not treated before… (32)

  • Letter by Marc Wathelet, PhD, to the Belgian Minister of Health1616107081563b by Covexit October 20, 2021 Note: an Addendum has been added this November 24th, to include new evidence from an article published in the prestigious… (58)

  • Dr. Mark McDonald – Part 1 – Covid & the United States of Fear – a Psychiatric Perspective on Vaccination, Mandates & Authoritarianismmark_mcdonald_part1.1040 by Covexit November 12, 2021 This is Part 1 of my interview with Dr. Mark McDonald, Medical Doctor and Psychiatrist from California. We discuss the… (79)

Twitter feed is not available at the moment.

About this Blog

This is a blog by Jean-Pierre Kiekens, an Oxford graduate and former university lecturer, presenting opinions, news and independent policy analysis about the pandemic with focus on early treatments. This website does NOT provide any therapeutic advice. For that, please refer yourself to your doctor or health care provider.

The Covexit.com Podcast

For more news and discussions, join our (uncensored) group!

And we also have a group on Telegram!

WordPress Theme: Donovan by ThemeZee.

Greetings and welcome. COVEXIT.com offers you independent global news and policy analysis regarding COVID-19, with emphasis on early treatments.

We are on Spotify and Apple Podcasts!  Check our page listing all our podcasts.
We are on Twitter and also on GAB  and Mewe. 


Greetings. We will soon have some new content via Substack. You are welcome to subscribe at:
covexit.substack.com

Bonjour. Nous aurons prochainement du contenu nouveau via Substack. Vous êtes invité à vous y abonner!